Firefly Neuroscience, Inc. (NASDAQ:AIFF) Financings

Firefly Neuroscience, Inc.

Financings

RaiseDate
Warrant exercise of common stock on exercise of warrants
Closed: US$8.82M raised
Use of proceeds: General working capital, including the initiative to build a foundation model of the human brain using its BNA technology platform
Feb 21, 2025
Senior secured convertible notes
Closed: US$2.4M raised
Use of proceeds: Growth, commercialization of its FDA-510(k) cleared BNA technology, and general working capital
Dec 31, 2024
Equity line of credit
Announced: up to US$10M
Use of proceeds: Growth, commercialization of its FDA-510(k) cleared BNA technology, and general working capital
Dec 31, 2024

Read by 6ix AI from the company's releases